Lung diagnostics has taken a revolutionary leap with L&T Technology Services unveiling an AI-powered digital twin platform that transforms how clinicians visualize and navigate the lungs.
Leveraging LTTS’ expertise in platform engineering, AI-driven diagnostics, connected health systems, and advanced imaging, combined with NVIDIA’s cutting-edge AI infrastructure, the company aims to deliver scalable, low-latency solutions that enhance diagnostic precision and improve healthcare accessibility worldwide.
The platform, set to debut at the Radiological Society of North America (RSNA) 2025, integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy. Clinicians can now visualize airways, blood vessels, lung lobes, and lesions in an interactive, real-time format.
Powered by NVIDIA MONAI for medical image segmentation and NVIDIA TensorRT for optimized AI inference, the digital twin enables precise path planning and navigation support for bronchoscopy, helping medical teams tackle complex procedures more efficiently.
“AI is reshaping what’s possible in diagnostics and medical technology,” said Alind Saxena, Executive Director and President of Mobility and Tech at L&T Technology Services.
“Our collaboration with NVIDIA combines LTTS’ expertise in AI-driven diagnostics and predictive analytics, with NVIDIA’s powerful, modeling and visualization platform. This lets us engineer a digital twin platform that not only enhances diagnostic accuracy but also gives clinicians an immersive, real-time planning tool ultimately helping deliver better outcomes for patients around the world.”
LTTS’ proprietary navigation systems and deep domain engineering in medical imaging transform static scans into dynamic, evolving models that mirror real-world anatomy, offering intuitive, clinically meaningful simulations. The platform aims to advance care for serious conditions such as lung cancer, COPD, and infectious diseases, redefining surgical planning and patient treatment.
“Working with LTTS to accelerate the development of AI-enabled medical technology demonstrates how NVIDIA is empowering the healthcare industry with accelerated computing and AI innovation,” said David Niewolny, Director of Business Development for Healthcare/Medical at NVIDIA.
“LTTS is enabling transformative solutions that bring the vision of real-time AI and biological digital twins powered by NVIDIA to clinical practice—delivering interactive, real-time visualization and intelligent guidance to help clinicians provide higher-quality care and achieve better outcomes for patients.”
